Menu Back toInstructors

#44: The Good Pharmacovigilance Practices in the EU: Global Applications


  • Steve  Jolley, MA

    Steve Jolley, MA

    • Chief Executive Officer
    • SJ Pharma Consulting, LLC, United States

    Steve Jolley is a subject matter expert in all areas of global safety compliance and signal detection, and is a frequent speaker at leading industry events. Steve has 30 years’ experience in drug safety and pharmacovigilance and has worked with over 100 clients in North America, Europe, Japan, India and China. He holds degrees in mathematics and computer science from Cambridge University, England. He is an Adjunct Professor at Rutgers University and teaches part of their Master’s degree in Drug Safety and Pharmacovigilance.

  • Saad  Shakir, DrMed, MD, FFPM, FISPE, FRCP

    Saad Shakir, DrMed, MD, FFPM, FISPE, FRCP

    • Director
    • Drug Safety Research Unit, United Kingdom

    Saad Shakir is Director of the Drug Safety Research Unit (DSRU) in Southampton. The DSRU is an academic Unit associated with the University of Portsmouth. Here he leads a research team with an active programme for monitoring and studying the safety of medicines. He has worked and advised on many drug safety issues including product withdrawals and major safety hazards. He is an author of many publications on pharmacovigilance and pharmacoepidemiology.